
CDTRP 2025 Research Innovation Grant Competition Results
CDTRP is thrilled to announce the results of the CDTRP 2025 Research Innovation Grant Competition, made possible through our partnership with various esteemed organizations. We are proud to showcase all of the exciting projects that have been funded in this year’s competition.
We would like to extend our warmest congratulations to Dr. Marie-Chantal Fortin and her team for being awarded the CDTRP UdeM Research Innovation Grant. We wish them all the best as they embark on their innovative project!
“I warmly congratulate Dr. Marie-Chantal Fortin on winning the CDTRP Innovation Grant in the 2025 competition for her project entitled “Kidney Transplant Stakeholders’ Perspectives on the Future of Xenotransplantation”.
This project is perfectly aligned with the mission of the Université de Montréal Transplant Program to improve the care of transplant donors, families and patients through research and clinical innovation. We are proud to contribute to the CDTRP grant competitions and thus participate in transplantation and organ donation research in Canada.”
Ekat Kritikou, Vice-Dean, Research and Development, Faculty of Medicine, Université de Montréal
CDTRP UdeM Research Innovation Grant : Dr. Marie-Chantal Fortin
Project Title: Kidney Transplant Stakeholders’ Perspectives on the Future of Xenotransplantation
Main affiliation: Université de Montréal
Theme: 3 – Engineer and Allocate Better Grafts
Lay Abstract
Xenotransplantation is an emerging technology for using organs from genetically-modified animals in human transplantation. In February 2025, American regulators approved the first clinical trials of pig kidney xenotransplantation. The use of xenotransplantation raises major ethical and social questions about, for example, how we treat animals as a society, how to fairly distribute the benefits of livesaving technologies, and even what it means to be human. Knowing how people think and feel about this new technology is vital for deciding whether and how it can be used in ethically and socially acceptable ways in Canada. Yet we have hardly any up-to-date information about Canadian perspectives on xenotransplantation.
To fill this gap, our project will explore the perspectives of groups who have a direct stake in (“stakeholders of”) kidney transplantation in Canada. These include organ recipents and donors, transplant candidates, family caregivers, and transplant professionals. Such stakeholders’ views are particularly valuable for understanding the potential impact of xenotransplantation on patient experiences, organ allocation, and other aspects of transplantation, as well as on broader society. They can also help us develop policies for using xenotransplantation in ways that will benefit patients and society and not be socially or ethically harmful. We will conduct individual and group interviews with professional and patient-related stakeholders of adult kidney transplantation. Based on our findings, we will make policy recommendations on future uses of xenotransplantation as well as plan a bigger public engagement research project.